{"story":{"id":930648,"title":"Mögliche Leberschäden unter MS-Arzneimittel Ocrelizumab - Deutsche Apotheker Zeitung, DAZ","permalink":"https://checknews.org/historia.php?id=930648","status":"quiet","category":"general","country":"DE","country_name":"Germany","language":"de","first_seen_at":"2026-10-07T21:30:00-06:00","last_activity_at":"2026-10-07T21:30:00-06:00","source_count":1,"article_count":1,"image":null,"articles":[{"title":"Mögliche Leberschäden unter MS-Arzneimittel Ocrelizumab - Deutsche Apotheker Zeitung, DAZ","publisher":"Deutsche Apotheker Zeitung, DAZ","url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOcHRyWldISVBpaFluVHdHZVVvMk1JNFNuSFZpTllxR1EwX1cwVnR0X2lrTnhqZUgtNUJNak82R0sxQnBMdGk1S1NDMThIdG5uVEUtd2FCVmtjN2hHYmZfczJXVlhOcHJDNS04QjVJbzh3cC1HTU5lejBIUXV4M0d5TEh6TExMT3ZPNTZydXBqdEJYQndYLXhjYmZJVzBHQVN5UzZndmZYYlNWSHJKUzJhaDd3bw?oc=5","country":"DE","country_name":"Germany","language":"de","published_at":"2026-10-07T21:30:00-06:00"}],"source_url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOcHRyWldISVBpaFluVHdHZVVvMk1JNFNuSFZpTllxR1EwX1cwVnR0X2lrTnhqZUgtNUJNak82R0sxQnBMdGk1S1NDMThIdG5uVEUtd2FCVmtjN2hHYmZfczJXVlhOcHJDNS04QjVJbzh3cC1HTU5lejBIUXV4M0d5TEh6TExMT3ZPNTZydXBqdEJYQndYLXhjYmZJVzBHQVN5UzZndmZYYlNWSHJKUzJhaDd3bw?oc=5","publishers":[{"name":"Deutsche Apotheker Zeitung, DAZ","country":"DE","country_name":"Germany"}],"countries":["DE"]},"generated_at":"2026-11-19T02:48:15-06:00"}